Reproduction permitted for personal use only. For reprints and reprint permission, contact

NimbleGen researcher to lead $415K DNA project

Madison, Wis. - NimbleGen Systems scientist Thomas Albert will lead a federally funded investigation into new and innovative uses for microarray technology in DNA sequence analysis, the company announced.

Albert, director of advanced research for NimbleGen, will be the lead investigator on a two-year, $415,000 grant award that is part of the federal government's $3.4 million Cancer Genome Atlas pilot project.

His work will expand on earlier NimbleGen research into new uses of microarray technology for the selection of genomic regions for DNA sequence analysis. The company believes targeted sequencing can lead to the development of advanced analytical capabilities that have applications in research and healthcare.

The Cancer Genome Atlas Project is being conducted by the National Cancer Institute and the National Human Genome Research Institute. Both organizations are part of the National Institutes of Health.

Related stories
NimbleGen to discontinue IPO after Roche's $272.5 million acquisition

Tom Still: Wisconsin IPOs are a harbinger of growing tech economy

IPO-bound NimbleGen traveling in fast company

Madison biotech NimbleGen files for IPO; one of states' best-funded firms

Genomics researcher Hood joins NimbleGen board

-Add Your Comment


Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact

WTN Media Presents